Skip to content

Clinical trials

Phase 3 Central Nervous System Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Phase: Phase 3 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20162
20182
20191
20202
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Amzell1
AstraZeneca1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Guerbet1
Hoffmann-La Roche1
Remedy Pharmaceuticals, Inc.1
Xenon Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases14
Brain Diseases12
Nervous System Diseases9
Movement Disorders7
Neurodegenerative Diseases7
Mental Disorders5
Parkinson Disease4
Parkinsonian Disorders4
Tic Disorders3
Tourette Syndrome3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.